ND HB1103

Amends the definition of "medication unit" to mean a geographically separate facility affiliated with an opioid treatment program where licensed practitioners dispense or administer opioid treatment medication or collect drug test samples.

Requires medication units to operate under an opioid treatment program license and hold both a separate Drug Enforcement Administration registration and a medication unit license from the Department of Human Services.

Mandates the department adopt rules for medication unit licensing and monitoring, including standards for approval and maintenance of licensure, community engagement in need assessment, and patient care standards.

Changes the substance abuse treatment program license period from two years to three years.

Establishes a nonrefundable application fee of $150 for licensure applicants, with all fees collected used to defray administration and enforcement costs.